(redirected from subcutaneous infusion)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.


noun imbruement, imbuement, impregnation, inculcation, infiltration, infusio, injection, insertion, instillation, introduction, penetration, permeation
See also: incorporation

INFUSION, med. jur. A pharmaceutical operation, which consists in pouring a hot or cold fluid upon a substance, whose medical properties it is desired to extract. Infusion is also used for the product of this operation. Although infusion differs from decoction, (q.v.) they are said to be ejusdem generis; and in the case of an indictment which charged the prisoner with giving a decoction, and the evidence was that he had given an infusion, the difference was held to be immaterial. 8 Camp. R. 74.

References in periodicals archive ?
Additionally, the expanded indications include subcutaneous infusion of CUVITRU Immune Globulin Infusion (Human) 20% (Shire);GAMMAGARD LIQUID, Immune Globulin Infusion (Human) 10% (Shire); As well as Hizentra, Immune Globulin Subcutaneous (Human), 20% Liquid (CSL Behring)
Therefore, continuous subcutaneous infusion is the preferred mode of administration.
Continuous computerised subcutaneous infusions present new challenges (9,16).
van Laar T, van Hilten B, Neef C, et al: The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study.
1,2,6-14 Continuous subcutaneous infusion (CSI) of analgesics may be an alternative for pain control in patients without an epidural catheter, or in patients undergoing anti-coagulant therapy.
For subcutaneous infusion, there is no need for extra manipulations; the insulin pump cartridge is filled with pure' insulin (3 ml for the pumps used in this study).
Treprostinil is administered using a subcutaneous infusion pump that is significantly smaller than the intravenous pump required for epoprostenol administration.
Alternatively, the drug can be given as a continuous intravenous or subcutaneous infusion at 20 mcg/hr.
It is the only alternative to deferoxamine--which is administered overnight for 8-12 hours by subcutaneous infusion, usually into the abdomen, 5-7 days per week.
The company added that iNDiGO is a 16-week, international, multicentre, randomised, double-blind, placebo controlled, parallel group study designed to compare the efficacy, safety and tolerability of continuous subcutaneous infusion of adjunct ND0612L therapy with oral standard-of-care and placebo in patients who suffer from motor fluctuations despite optimized standard-of-care therapy.
Contract notice: Purchase of subcutaneous infusion to hospitals in southern denmark and region zealand.

Full browser ?